Probing Tumour Proteostasis and the UPR with Serum Markers

0 avis

Probing Tumour Proteostasis and the UPR with Serum Markers

Archive ouverte

Galmiche, Antoine | Sauzay, Chloé | Houessinon, Aline | Chauffert, Bruno | Pluquet, Olivier

International audience. Tumour proteostasis and the unfolded protein response (UPR) are emerging drivers of tumour progression and important determinants of clinical efficacy of cancer therapy. Recent findings indicate that they also regulate the production of protein tumour markers. Here, we discuss how this new knowledge opens up new perspectives for cancer therapeutics.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

Archive ouverte | Houessinon, Aline | CCSD

International audience. Background: Sorafenib, a kinase inhibitor active against various solid tumours, induces oxidative stress and ferroptosis, a new form of oxidative necrosis, in some cancer cells. Clinically-ap...

Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma

Archive ouverte | Sauzay, Chloé | CCSD

International audience. Alpha-foetoprotein (AFP), one of the first protein tumour markers discovered, is widely used today in clinical practice. Its application for the screening and diagnosis of hepatocellular carc...

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases

Archive ouverte | Houessinon, Aline | CCSD

International audience. The survival of patients with head and neck squamous cancer with locoregional recurrence is short if salvage surgery or radiation cannot be performed. Systemic chemotherapy based on platinum ...

Chargement des enrichissements...